About: Sitagliptin     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Sitagliptin je perorální antidiabetikum, využivajici učinky inkretinovych hormonů. Jedna se o specificky inhibitor enzymu DPP-4 (dipeptidyl peptidase-4), ktery ovlivňuje degradaci a aktivitu inkretinovych hormonů, GLP-1 (glucagon-like peptide ? 1) a GIP (glucose-dependent insulinotropic polypeptide). Sitagliptin je charakterizovan velmi malym rizikem hypoglykemii v průběhu lečby, redukuje HbA1C, neovlivňuje tělesnou hmotnost a je velmi dobře snášen. Nejvice je využivan v kombinačni lečbě s metforminem a glitazony. V experimentalnich studiich inhibuje apoptozu a stimuluje proliferaci beta-buněk pankreatu, což vede k narůstu jejich množstvi.
  • Sitagliptin je perorální antidiabetikum, využivajici učinky inkretinovych hormonů. Jedna se o specificky inhibitor enzymu DPP-4 (dipeptidyl peptidase-4), ktery ovlivňuje degradaci a aktivitu inkretinovych hormonů, GLP-1 (glucagon-like peptide ? 1) a GIP (glucose-dependent insulinotropic polypeptide). Sitagliptin je charakterizovan velmi malym rizikem hypoglykemii v průběhu lečby, redukuje HbA1C, neovlivňuje tělesnou hmotnost a je velmi dobře snášen. Nejvice je využivan v kombinačni lečbě s metforminem a glitazony. V experimentalnich studiich inhibuje apoptozu a stimuluje proliferaci beta-buněk pankreatu, což vede k narůstu jejich množstvi. (cs)
  • Sitagliptin is an oral antidiabetic incretin-based drug. It is a specific inhibitor of DPP-4 (dipeptidyl peptidase-4), which regulates the degradation and the bioactivity of native GLP-1 (glucagon-like peptide ? 1) and GIP (glucose-dependent insulinotropic polypeptide). Sitagliptin is characterized by low incidence of hypoglycemia during the therapy. Sitagliptin reduces mean HbA1c and has a neutral inpact on body weight. Sitagliptin is generally well tolerated, with no significant side effects. Sitagliptin is being used in combination with metformin and thiazonlidindiones. In experimental studies sitagliptin inhibits apoptosis of islets beta-cells and stimulates their proliferation, which results in increasing of beta-cell mass. (en)
Title
  • Sitagliptin (en)
  • Sitagliptin (cs)
  • Sitagliptin
skos:prefLabel
  • Sitagliptin (en)
  • Sitagliptin (cs)
  • Sitagliptin
skos:notation
  • RIV/61989592:15110/09:10223534!RIV12-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • S
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 341463
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/09:10223534
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • type 2 diabetes mellitus; GIP; GLP-1; incretin hormones; DPP-4 inhibitors; sitagliptin (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • CZ - Česká republika
http://linked.open...ontrolniKodProRIV
  • [01560DC7A41F]
http://linked.open...i/riv/nazevZdroje
  • Klinická farmakologie a farmacie
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 23
http://linked.open...iv/tvurceVysledku
  • Krystyník, Ondřej
issn
  • 1212-7973
number of pages
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 75 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software